Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01463046
Title Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of California, San Francisco
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94143 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field